172 related articles for article (PubMed ID: 31040643)
1. Transportan-derived cell-penetrating peptide delivers siRNA to inhibit replication of influenza virus in vivo.
Zhang C; Ren W; Liu Q; Tan Z; Li J; Tong C
Drug Des Devel Ther; 2019; 13():1059-1068. PubMed ID: 31040643
[TBL] [Abstract][Full Text] [Related]
2. Protein and siRNA delivery by transportan and transportan 10 into colorectal cancer cell lines.
Wierzbicki PM; Kogut-Wierzbicka M; Ruczynski J; Siedlecka-Kroplewska K; Kaszubowska L; Rybarczyk A; Alenowicz M; Rekowski P; Kmiec Z
Folia Histochem Cytobiol; 2014; 52(4):270-80. PubMed ID: 25511292
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of influenza A virus by mixed siRNAs, targeting the PA, NP, and NS genes, delivered by hybrid microcarriers.
Brodskaia AV; Timin AS; Gorshkov AN; Muslimov AR; Bondarenko AB; Tarakanchikova YV; Zabrodskaya YA; Baranovskaya IL; Il'inskaja EV; Sakhenberg EI; Sukhorukov GB; Vasin AV
Antiviral Res; 2018 Oct; 158():147-160. PubMed ID: 30092251
[TBL] [Abstract][Full Text] [Related]
4. Label-Free Confocal Raman Mapping of Transportan in Melanoma Cells.
Cosme PJ; Ye J; Sears S; Wojcikiewicz EP; Terentis AC
Mol Pharm; 2018 Mar; 15(3):851-860. PubMed ID: 29397737
[TBL] [Abstract][Full Text] [Related]
5. Intracellular delivery of siRNA by cell-penetrating peptides modified with cationic oligopeptides.
Ishihara T; Goto M; Kodera K; Kanazawa H; Murakami Y; Mizushima Y; Higaki M
Drug Deliv; 2009 Apr; 16(3):153-9. PubMed ID: 19514975
[TBL] [Abstract][Full Text] [Related]
6. Expression of a single siRNA against a conserved region of NP gene strongly inhibits in vitro replication of different Influenza A virus strains of avian and swine origin.
Stoppani E; Bassi I; Dotti S; Lizier M; Ferrari M; Lucchini F
Antiviral Res; 2015 Aug; 120():16-22. PubMed ID: 25986248
[TBL] [Abstract][Full Text] [Related]
7. Hybrid inorganic-organic capsules for efficient intracellular delivery of novel siRNAs against influenza A (H1N1) virus infection.
Timin AS; Muslimov AR; Petrova AV; Lepik KV; Okilova MV; Vasin AV; Afanasyev BV; Sukhorukov GB
Sci Rep; 2017 Mar; 7(1):102. PubMed ID: 28273907
[TBL] [Abstract][Full Text] [Related]
8. High yield production of influenza virus in Madin Darby canine kidney (MDCK) cells with stable knockdown of IRF7.
Hamamoto I; Takaku H; Tashiro M; Yamamoto N
PLoS One; 2013; 8(3):e59892. PubMed ID: 23555825
[TBL] [Abstract][Full Text] [Related]
9. Efficient Inhibition of Avian and Seasonal Influenza A Viruses by a Virus-Specific Dicer-Substrate Small Interfering RNA Swarm in Human Monocyte-Derived Macrophages and Dendritic Cells.
Jiang M; Österlund P; Westenius V; Guo D; Poranen MM; Bamford DH; Julkunen I
J Virol; 2019 Feb; 93(4):. PubMed ID: 30463970
[TBL] [Abstract][Full Text] [Related]
10. Cell-penetrating peptides, PepFects, show no evidence of toxicity and immunogenicity in vitro and in vivo.
Suhorutsenko J; Oskolkov N; Arukuusk P; Kurrikoff K; Eriste E; Copolovici DM; Langel U
Bioconjug Chem; 2011 Nov; 22(11):2255-62. PubMed ID: 21978260
[TBL] [Abstract][Full Text] [Related]
11. Blood pressure modulation following activation of mast cells by cationic cell penetrating peptides.
Basheer M; Schwalb H; Shefler I; Levdansky L; Mekori YA; Gorodetsky R
Peptides; 2011 Dec; 32(12):2444-51. PubMed ID: 21971370
[TBL] [Abstract][Full Text] [Related]
12. Cell penetrating peptides fail to induce an innate immune response in epithelial cells in vitro: implications for continued therapeutic use.
Carter E; Lau CY; Tosh D; Ward SG; Mrsny RJ
Eur J Pharm Biopharm; 2013 Sep; 85(1):12-9. PubMed ID: 23958314
[TBL] [Abstract][Full Text] [Related]
13. Passage of cell-penetrating peptides across a human epithelial cell layer in vitro.
Lindgren ME; Hällbrink MM; Elmquist AM; Langel U
Biochem J; 2004 Jan; 377(Pt 1):69-76. PubMed ID: 12968950
[TBL] [Abstract][Full Text] [Related]
14. Effective small interfering RNAs targeting matrix and nucleocapsid protein gene inhibit influenza A virus replication in cells and mice.
Zhou H; Jin M; Yu Z; Xu X; Peng Y; Wu H; Liu J; Liu H; Cao S; Chen H
Antiviral Res; 2007 Nov; 76(2):186-93. PubMed ID: 17719657
[TBL] [Abstract][Full Text] [Related]
15. Cholesterol prevents interaction of the cell-penetrating peptide transportan with model lipid membranes.
Arsov Z; Nemec M; Schara M; Johansson H; Langel U; Zorko M
J Pept Sci; 2008 Dec; 14(12):1303-8. PubMed ID: 18683276
[TBL] [Abstract][Full Text] [Related]
16. Identification of cell-penetrating peptides that are bactericidal to Neisseria meningitidis and prevent inflammatory responses upon infection.
Eriksson OS; Geörg M; Sjölinder H; Sillard R; Lindberg S; Langel U; Jonsson AB
Antimicrob Agents Chemother; 2013 Aug; 57(8):3704-12. PubMed ID: 23689723
[TBL] [Abstract][Full Text] [Related]
17. Characterisation of cell-penetrating peptide-mediated peptide delivery.
Jones SW; Christison R; Bundell K; Voyce CJ; Brockbank SM; Newham P; Lindsay MA
Br J Pharmacol; 2005 Aug; 145(8):1093-102. PubMed ID: 15937518
[TBL] [Abstract][Full Text] [Related]
18. A myristoylated cell-penetrating peptide bearing a transferrin receptor-targeting sequence for neuro-targeted siRNA delivery.
Youn P; Chen Y; Furgeson DY
Mol Pharm; 2014 Feb; 11(2):486-95. PubMed ID: 24387132
[TBL] [Abstract][Full Text] [Related]
19. Cell-Penetrating Mx1 Enhances Anti-Viral Resistance against Mucosal Influenza Viral Infection.
Jung HE; Oh JE; Lee HK
Viruses; 2019 Jan; 11(2):. PubMed ID: 30696001
[TBL] [Abstract][Full Text] [Related]
20. Construction of influenza virus siRNA expression vectors and their inhibitory effects on multiplication of influenza virus.
Li YC; Kong LH; Cheng BZ; Li KS
Avian Dis; 2005 Dec; 49(4):562-73. PubMed ID: 16405000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
